Mesothelioma among seamen: a systematic review and meta-analysis

被引:0
|
作者
Rota, Matteo [1 ]
Viscardi, Angelo [2 ]
Maghin, Francesca [3 ,4 ,5 ]
Placidi, Donatella [2 ]
Conti, Adelaide [3 ,4 ]
机构
[1] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy
[2] Univ Brescia, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, I-25121 Brescia, Italy
[3] Univ Brescia, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Forens Med Unit, Piazzale Spedali Civili 1, I-25123 Brescia, Italy
[4] ASST Spedali Civili Brescia, Piazzale Spedali Civili 1, Brescia, Italy
[5] Natl Inst Insurance Accid Work INAIL, Brescia, Italy
关键词
asbestos; meta-analysis; mesothelioma; navy; seafarers; CANCER INCIDENCE; PLEURAL MESOTHELIOMA; UNITED-STATES; ASBESTOS; MORTALITY; RISK; SERVICEMEN; EXPOSURE; BIAS;
D O I
10.1097/CEJ.0000000000000875
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectivesNavy personnel and seafarers live and work 24 h per day in the shipboard environment and they are exposed to asbestos fibers released into the confined spaces aboard ships. We conducted a systematic review and meta-analysis to quantify the mesothelioma risk of seamen working aboard ships, either commercial or naval vessels, as compared to that of the general population.MethodsWe carried out a literature search in MEDLINE through PubMed and EMBASE, from inception to 31 December 2021, of all studies on seamen working aboard ships, either commercial or naval vessels, characterized by exposure to asbestos and providing mesothelioma risk estimates. The Newcastle-Ottawa Scale was used to assess the quality of the studies included. The pooled standardized mortality ratio (SMR) was computed across eligible studies. The study protocol was registered on PROSPERO and reporting followed the preferred reporting items for systematic reviews and meta-analyses guidelines.ResultsA total of 10 studies published from 1990 to 2020 were considered eligible and included in the systematic review and meta-analysis. All the included studies were of good quality, with a median score of seven out of nine. Overall, there were 235 mesothelioma cases/deaths in the included studies versus 115.6 expected, with a pooled SMR of 2.11 (95% confidence intervals, 1.70-2.62), in the absence of a significant between-study heterogeneity (I2 = 39%, P = 0.11).ConclusionA more than double excess risk for mesothelioma among seamen working aboard ships emerged from our meta-analysis.
引用
收藏
页码:438 / 447
页数:10
相关论文
共 50 条
  • [1] A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma
    Cao, Christopher
    Tian, David
    Park, John
    Allan, James
    Pataky, Kristopher A.
    Yan, Tristan D.
    LUNG CANCER, 2014, 83 (02) : 240 - 245
  • [2] A SYSTEMATIC REVIEW AND META-ANALYSIS OF REFINERY WORKERS AND RISK OF MESOTHELIOMA.
    McKinley, Meg
    Roberts, Lauren
    Ward, Rebecca
    Gale, Sara
    Capshaw, Zachary
    Anderson, Grace
    Chen, Connie
    Barlow, Christy
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 : S76 - S76
  • [3] Mesothelioma among Motor Vehicle Mechanics: An Updated Review and Meta-analysis
    Garabrant, David H.
    Alexander, Dominik D.
    Miller, Paula E.
    Fryzek, Jon P.
    Boffetta, Paolo
    Teta, M. J.
    Hessel, Patrick A.
    Craven, Valerie A.
    Kelsh, Michael A.
    Goodman, Michael
    ANNALS OF OCCUPATIONAL HYGIENE, 2016, 60 (01): : 8 - 26
  • [4] Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma
    Lu, Zhenhua
    Zhang, Wenlong
    Huang, Ke
    Zhu, Mucheng
    Gu, Xiaoting
    Wei, Defang
    Shi, Mingxuan
    Chen, Yaqiong
    Wang, Huihui
    DIAGNOSTICS, 2022, 12 (09)
  • [5] Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysis
    Hu, Zhi-De
    Liu, Xiao-Fei
    Liu, Xiao-Cui
    Ding, Chun-Mei
    Hu, Cheng-Jin
    CLINICA CHIMICA ACTA, 2014, 433 : 44 - 48
  • [6] Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis
    Berghmans, T
    Paesmans, M
    Lalami, Y
    Louviaux, I
    Luce, S
    Mascaux, C
    Meert, AP
    Sculier, JP
    LUNG CANCER, 2002, 38 (02) : 111 - 121
  • [7] DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis
    Vandenhoeck, Janah
    van Meerbeeck, Jan P.
    Fransen, Erik
    Raskin, Jo
    Van Camp, Guy
    Op de Beeck, Ken
    Lamote, Kevin
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (09) : 1461 - 1478
  • [8] Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
    Gemelli, Maria
    Cortinovis, Diego Luigi
    Baggi, Alice
    di Mauro, Pierluigi
    Calza, Stefano
    Berruti, Alfredo
    Grisanti, Salvatore
    Rota, Matteo
    CANCERS, 2022, 14 (24)
  • [9] A systematic review and meta-analysis of second-line therapies for treatment of mesothelioma
    Petrelli, Fausto
    Ardito, Raffaele
    Conti, Barbara
    Coinu, Andrea
    Cabiddu, Mary
    Ghilardi, Mara
    Borgonovo, Karen
    Barni, Sandro
    Ghidini, Antonio
    RESPIRATORY MEDICINE, 2018, 141 : 72 - 80
  • [10] Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
    Jarvinen, Tommi
    Paajanen, Juuso
    Ilonen, Ilkka
    Rasanen, Jari
    CANCERS, 2021, 13 (14)